Genmab A (GMAB) EBT (2018 - 2026)

Genmab A (GMAB) posted EBT of $74.0 million for Q1 2026, down 93.56% on a QoQ basis from $1.1 billion in Q3 2025, and down 69.67% year-over-year from $244.0 million in Q1 2025.

Genmab A (GMAB) EBT (2018 - 2026) Analysis & Trends

Genmab A's EBT history runs 6 years deep, the most recent figure standing at $74.0 million for Q1 2026.

  • Quarterly EBT fell 69.67% year-over-year to $74.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 billion (down 27.29% YoY) and the FY2025 annual result came in at $1.2 billion, up 32.45% from the prior year.
  • EBT was $74.0 million for Q1 2026 at Genmab A, down from $1.1 billion in the prior quarter.
  • Across five years, EBT topped out at $1.3 billion in Q4 2024 and bottomed at $74.0 million in Q1 2026.
  • A 3-year average of $634.2 million and a median of $611.5 million in 2024 frame the typical range for EBT.
  • Annual changes were most pronounced in 2025 — EBT jumped 42.03% — and 2026, when it plunged 69.67%.
  • Genmab A's EBT stood at $1.3 billion in 2024, then dropped by 13.35% to $1.1 billion in 2025, then plunged by 93.56% to $74.0 million in 2026.
  • Business Quant data shows GMAB's EBT at $74.0 million in Q1 2026, $1.1 billion in Q3 2025, and $667.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -36.97 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 259.22 Mn
4 NuCana 279.75 Bn 279.75 Bn - -3.49 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.25 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 831.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -26.94 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 541.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -453.82 Mn
10 Genmab A 1.89 Bn 366.92 Mn 831.00 Mn 74.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 74.00 Mn
Sep 30, 2025 1.15 Bn
Jun 30, 2025 667.00 Mn
Mar 31, 2025 244.00 Mn
Dec 31, 2024 1.33 Bn
Sep 30, 2024 809.00 Mn
Jun 30, 2024 556.00 Mn
Mar 31, 2024 249.00 Mn
Sep 30, 2020 671.00
Dec 31, 2019 699.00
Sep 30, 2019 699.28 Mn
Dec 31, 2018 230.60 Mn